Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
OptimizeRx Corporation provides various solutions to life sciences organizations, healthcare providers, and patients. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $43.3M | $61.3M | $62.5M | $71.5M | $92.1M | $109.4M |
| Gross profit | $24.1M | $35.6M | $39.0M | $42.9M | $59.4M | $73.6M |
| Operating income | -$2.1M | $361,100.00 | -$12.3M | -$26.4M | -$13.7M | $11.7M |
| Net income | -$2.2M | $378,079.00 | -$11.4M | -$17.6M | -$20.1M | $5.1M |
| Diluted EPS | -$0.15 | $0.02 | -$0.64 | -$1.03 | -$1.10 | $0.27 |
| Operating cash flow | -$6.3M | $726,039.00 | $10.7M | -$7.2M | $4.9M | $18.7M |
| Free cash flow | -$6.4M | $625,717.00 | $10.6M | -$7.3M | $4.8M | $18.7M |
| Gross margin | 55.7% | 58.1% | 62.4% | 60.0% | 64.5% | 67.3% |
| Operating margin | -4.9% | 0.6% | -19.7% | -36.9% | -14.9% | 10.7% |
| Net margin | -5.1% | 0.6% | -18.3% | -24.6% | -21.8% | 4.7% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18.8M | $21.3M | $32.3M | $21.9M | $29.2M | $26.1M | $32.2M | $19.8M |
| Gross profit | $11.7M | $13.4M | $22.0M | $13.3M | $18.6M | $17.5M | $24.1M | — |
| Operating income | -$3.7M | -$8.6M | $3.6M | -$2.1M | $3.2M | $2.0M | $8.6M | $396,000.00 |
| Net income | -$4.0M | -$9.1M | -$78,000.00 | -$2.2M | $1.5M | $779,000.00 | $5.0M | -$495,000.00 |
| Diluted EPS | -$0.22 | -$0.50 | $0.00 | -$0.12 | $0.08 | $0.04 | $0.27 | -$0.03 |
| Operating cash flow | $782,000.00 | $1.8M | $198,000.00 | $3.9M | $4.6M | $3.2M | $7.1M | -$467,000.00 |
| Free cash flow | $737,000.00 | $1.8M | $181,000.00 | $3.8M | $4.6M | $3.2M | $7.1M | -$488,000.00 |
| Gross margin | 62.2% | 63.1% | 68.1% | 60.9% | 63.8% | 67.2% | 74.8% | — |
| Operating margin | -19.9% | -40.2% | 11.2% | -9.6% | 10.9% | 7.9% | 26.5% | 2.0% |
| Net margin | -21.3% | -42.8% | -0.2% | -10.0% | 5.2% | 3.0% | 15.6% | -2.5% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-09 | Spangler Patrick D | Award | 34,517 | $0.00 | $0.00 | filing |
| 2026-06-09 | Lang James Paul | Award | 34,517 | $0.00 | $0.00 | filing |
| 2026-06-09 | Presti Mariyamma Varghese | Award | 17,258 | $0.00 | $0.00 | filing |
| 2026-06-09 | KLEMA CATHY | Award | 34,517 | $0.00 | $0.00 | filing |
| 2026-06-09 | Vos Ellen O'Connor | Award | 34,517 | $0.00 | $0.00 | filing |
| 2026-06-09 | WASSON GREGORY D | Award | 34,517 | $0.00 | $0.00 | filing |
| 2026-05-15 | Silvestro Stephen L· Chief Executive Officer | Tax withholding | 5,219 | $5.21 | $27,190.99 | filing |
| 2026-05-15 | Greco Theresa· Chief Commercial Officer | Tax withholding | 914 | $5.21 | $4,761.94 | filing |
| 2026-05-15 | Greco Theresa· Chief Commercial Officer | Tax withholding | 879 | $5.21 | $4,579.59 | filing |
| 2026-05-01 | Presti Mariyamma Varghese | Award | 13,060 | $0.00 | $0.00 | filing |
| 2026-02-11 | Odence-Ford Marion· Chief Legal & Admin Officer | Tax withholding | 1,386 | $9.23 | $12,792.78 | filing |
| 2026-02-11 | Odence-Ford Marion· Chief Legal & Admin Officer | Option exercise | 4,000 | — | — | filing |
| 2025-12-23 | Besch Doug· Chief Product & Tech Officer | Tax withholding | 4,079 | $12.74 | $51,966.46 | filing |
| 2025-12-23 | Odence-Ford Marion· Chief Legal & Admin Officer | Tax withholding | 4,051 | $12.74 | $51,609.74 | filing |
| 2025-12-23 | Stelmakh Edward· Chief Finance & Strat Officer | Tax withholding | 3,658 | $12.74 | $46,602.92 | filing |
| 2025-12-23 | Silvestro Stephen L· Chief Executive Officer | Tax withholding | 3,361 | $12.74 | $42,819.14 | filing |
| 2025-12-23 | Silvestro Stephen L· Chief Executive Officer | Tax withholding | 3,361 | $12.74 | $42,819.14 | filing |
| 2025-12-23 | Greco Theresa· Chief Commercial Officer | Tax withholding | 1,420 | $12.74 | $18,090.80 | filing |
| 2025-12-19 | Silvestro Stephen L· Chief Executive Officer | Tax withholding | 1,594 | $13.51 | $21,534.94 | filing |
| 2025-12-19 | Stelmakh Edward· Chief Finance & Strat Officer | Tax withholding | 1,388 | $13.51 | $18,751.88 | filing |
| 2025-12-19 | Stelmakh Edward· Chief Finance & Strat Officer | Sale | 1,388 | $13.51 | $18,751.88 | filing |
| 2025-12-19 | Odence-Ford Marion· Chief Legal & Admin Officer | Tax withholding | 1,153 | $13.51 | $15,577.03 | filing |
| 2025-12-19 | D'Silva Andrew J.· Chief Business Officer | Tax withholding | 703 | $13.51 | $9,497.53 | filing |
| 2025-12-19 | Besch Doug· Chief Product & Tech Officer | Tax withholding | 581 | $13.51 | $7,849.31 | filing |
| 2025-12-19 | Merrell Brendan W.· CHIEF OPERATING OFFICER | Tax withholding | 289 | $13.51 | $3,904.39 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.